Intraoperative Allogeneic Blood Transfusion Has No Impact on Postoperative Short-Term Outcomes After Pancreatoduodenectomy for Periampullary Malignancies: A Propensity Score Matching Analysis and Mediation Analysis
<b>Background/Objectives</b>: The aim of this study was to investigate the association between intraoperative blood transfusion (BT) and the short-term outcomes of pancreatoduodenectomy (PD) for patients with periampullary malignancies. <b>Methods</b>: In a retrospective two-center cohort analysis, we utilized a logistic and mixed-effects ordinal regression, nonparametric partial correlation, and mediation analysis, complemented by propensity score matching (PSM) and weighting. <b>Results</b>: A total of 491 patients were included. Of these, 18 (3.7%) received an intraoperative BT. An intraoperative BT was associated with blood loss (odds ratio (OR) per 100 mL = 1.42; 95% CI 1.27 to 1.62; <i>p</i> < 0.001) and relatively high ASA classes (OR = 3.75; 95% CI 1.05 to 17.74; <i>p</i> = 0.041). Intraoperative blood loss (r = 0.27; <i>p</i> < 0.001) but not intraoperative BT (r = 0.015; <i>p</i> = 0.698) was associated with postoperative complications. Intraoperative BT was associated with postoperative complications according to the unadjusted regression (OR = 1.95; 95% CI 1.38-2.42, <i>p</i> < 0.001) but not the multivariable ordinal regression. In the mediation analysis for relative risk (RR), intraoperative BT was beneficial (RR = 0.51; 95% CI: 0.01-0.78), and blood loss (RR = 2.49; 95% CI: 1.75-177.34) contributed to the occurrence of major postoperative complications. After PSM, analyses revealed that an intraoperative BT did not have a significant impact on the rates of postoperative major complications (OR = 1.048; <i>p</i> = 0.919), clinically relevant postoperative pancreatic fistula (OR = 0.573; <i>p</i> = 0.439) or postoperative 90-day mortality (OR = 0.714; <i>p</i> = 0.439). <b>Conclusions</b>: When adjusting for intraoperative blood loss, intraoperative BT is not associated with postoperative complications.
Authors
- Thomas Steffen (ORCID: https://orcid.org/0000-0001-9374-5703)
- Kristjan Ukegjini (ORCID: https://orcid.org/0000-0002-3127-8852)
- René Warschkow (ORCID: https://orcid.org/0000-0001-9635-5751)
- Ignazio Tarantino (ORCID: https://orcid.org/0000-0003-2238-0000)
- José Oberholzer (ORCID: https://orcid.org/0000-0002-1069-2501)
- Henrik Petrowsky (ORCID: https://orcid.org/0000-0001-5744-0531)
- Philip C. Müller (ORCID: https://orcid.org/0000-0001-8317-3449)
- Bruno M. Schmied (ORCID: https://orcid.org/0000-0003-4552-7386)
- Jan Philipp Jonas (ORCID: https://orcid.org/0000-0002-3134-9040)
Institutions
- Kantonsspital St. Gallen (CH)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- Cancers
- Published
- 2024-10-18
- DOI
- https://doi.org/10.3390/cancers16203531
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28